At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
stereotactic radiosurgeryradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Feasibility and Outcome of Cyberknife® Stereotactic Radiosurgical Boost and Salvage Therapy for Head and Neck Cancer
In Brief
A clinical study evaluating stereotactic radiosurgery for Head and Neck Cancer. Completed, enrolled 12 participants across 1 site.
Detailed Summary
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects of stereotactic radiosurgery in treating patients with locally advanced or recurrent head and neck cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead and Neck Cancer
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedFeb 2009
Primary CompletionDec 2014
Study CompletionApr 2017
TodayJul 2026
First PostedFeb 25, 2009
Enrollment StartJan 1, 2009
Primary CompletionDec 1, 2014
Study CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 17.4 years ago
Interventions
stereotactic radiosurgeryradiation
Given in 2 fractionated doses or 5 fractionated doses